Lexicon Pharmaceuticals Inc.
LXRX | NASDAQ
$2.12
+$0.08 (+3.92%)
Sep 22, 2026, 1:03 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -32.82M | -1.04M | -15.53M | -12.77M | 3.25M | -25.3M | -33.77M | -64.81M | -53.43M | -48.4M | -49.76M | -50.53M | -44.9M | -31.93M | -30.49M | -23.39M | -24.59M | -23.48M | -25.61M | -23.12M | -18.07M | -20.96M |
Depreciation & Amortization | 212K | 110K | 118K | 151K | 176K | 176K | 125K | 126K | 139K | 144K | 147K | 151K | 144K | 112K | 103K | 108K | 107K | 109K | 112K | 101K | 42K | 37K |
Stock-Based Compensation | 6.41M | 3.08M | 2.84M | 3.44M | 3.2M | 3.04M | 1.54M | 2.8M | 4.86M | 4.3M | 3.21M | 3.9M | 3.82M | 3.42M | 3.27M | 2.65M | 2.83M | 2.77M | 2.23M | 2.71M | 2.79M | 2.85M |
Other Working Capital | 269K | -124K | 1.27M | -167K | -217K | 1.4M | 2.81M | 1.15M | -495K | -1.71M | -886K | 1.54M | -2.62M | -467K | 481K | 171K | -792K | 480K | 1.1M | 1.73M | -309K | 1.02M |
Other Non-Cash Items | 4.17M | -462K | -108K | 3.1M | -833K | -2.47M | -1.16M | -1.43M | -4.36M | 291K | 126K | -3M | 273K | 265K | 348K | 217K | 154K | 25K | 57K | 17K | 15K | 14K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.9M | -16.41M | -4.55M | -14.31M | 11.2M | -19.24M | 11.77M | 9.69M | 4.25M | -11.47M | -4.28M | 7.85M | 2.56M | -3.47M | 5.21M | 975K | -2.93M | -2.85M | 386K | 3.14M | -6.66M | -7.1M |
Operating Cash Flow | -23.92M | -14.73M | -17.23M | -23.83M | 16.99M | -43.78M | -21.49M | -53.62M | -48.54M | -55.13M | -50.55M | -41.62M | -38.12M | -31.61M | -21.57M | -19.44M | -24.42M | -23.42M | -22.83M | -17.15M | -21.88M | -25.16M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | -474K | -307K | -250K | n/a | n/a | -83K | -139K | -248K | -1.25M | -4K | n/a | -76K | -23K | -213K | -947K | -38K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 39.24M | n/a | n/a | -25.42M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -163.22M | -105.96M | -22.61M | -26.73M | -27.19M | -64.97M | -25.83M | -42.62M | -77.07M | -183.22M | -102K | -72.24M | -122.13M | -28.86M | -586K | -93.19M | -22.36M | -17.82M | -5.38M | -4.51M | -2.69M | -21.69M |
Sales Maturities Of Investments | 76.5M | 35.7M | 27M | 78.85M | 41.46M | 105.55M | 80M | 96.4M | 65M | 73M | 52M | 33M | 47.67M | 41.21M | 26.01M | 16M | 8.71M | 13.48M | 11.5M | 4.32M | 17.77M | 4M |
Other Investing Acitivies | n/a | n/a | 440K | n/a | 1.21M | n/a | n/a | n/a | n/a | n/a | n/a | -39.24M | n/a | n/a | 25.42M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -86.72M | -70.26M | 4.83M | 52.13M | 15.48M | 40.58M | 53.7M | 53.47M | -12.32M | -110.22M | 51.9M | -39.33M | -74.61M | 12.09M | 24.17M | -77.2M | -13.65M | -4.41M | 6.1M | -400K | 14.14M | -17.72M |
Debt Repayment | -4.26M | -5M | -3M | n/a | -45M | n/a | n/a | n/a | n/a | n/a | -1K | 1K | 49.96M | n/a | 24.97M | -249K | n/a | 24.15M | -11.7M | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | -572K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -824K | n/a | n/a | n/a | -864K | n/a | n/a | n/a | -2.68M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -5.12M | -2.84M | n/a | n/a | n/a | n/a | 63K | -906K | n/a | -2.13M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 88.24M | 88.76M | -2.93M | n/a | -45M | -572K | -104K | -916K | -14K | 239.38M | -1K | -210K | 189M | -824K | 24.91M | 94.02M | n/a | 23.28M | -11.32M | 19.78M | -23K | 14.27M |
Net Cash Flow | -22.4M | 3.76M | -15.33M | 28.29M | -12.52M | -3.77M | 32.11M | -1.07M | -60.88M | 74.03M | 1.35M | -81.16M | 76.27M | -20.34M | 27.51M | -2.62M | -38.07M | -4.55M | -28.05M | 2.23M | -7.77M | -28.61M |
Free Cash Flow | -23.92M | -14.73M | -17.23M | -23.83M | 16.99M | -43.78M | -21.97M | -53.93M | -48.79M | -55.13M | -50.55M | -41.7M | -38.26M | -31.86M | -22.82M | -19.44M | -24.42M | -23.5M | -22.85M | -17.36M | -22.83M | -25.2M |
Adj. Free Cash Flow | -30.34M | -17.81M | -20.07M | -27.28M | 13.8M | -46.82M | -23.5M | -56.73M | -53.65M | -59.43M | -53.76M | -45.6M | -42.07M | -35.28M | -26.08M | -22.09M | -27.25M | -26.27M | -25.08M | -20.08M | -25.61M | -28.05M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -102.37K | -78.62K | n/a | n/a | -66.48K | -101.12K | -248K | -1.24M | -1.83K | n/a | -74.64K | -23K | -213K | -947K | -38K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | -474K | -204.63K | -171.38K | n/a | n/a | -16.52K | -37.88K | n/a | -1.9K | -2.17K | n/a | -1.36K | n/a | n/a | n/a | n/a |
Owner Earnings | -23.92M | -14.73M | -17.23M | -23.83M | 16.99M | -43.78M | -21.49M | -53.72M | -48.62M | -55.13M | -50.55M | -41.69M | -38.22M | -31.86M | -22.81M | -19.44M | -24.42M | -23.5M | -22.85M | -17.36M | -22.83M | -25.2M |
Add to Watchlist
Select watchlists to add or remove LXRX